Clinical Trial Update: Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety and preliminary activity of KT-253 in adults with high-grade myeloid malignancies, acute lymphoblastic leukemia, lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Lymphoma
• Solid Tumors

Drugs mentioned

• KT-253

Snippet

Sponsor: Kymera Therapeutics, Inc. | Conditions: Myeloid Malignancies, Acute Lymphocytic Leukemia | Phase 1 | Status: COMPLETED